International Society on Thrombosis and Haemostasis, Inc.

Gasser El-Bishry, M.D.

Gasser El-Bishry was born in the UK, and he obtained his International Baccalaureate Diploma at the United World College of the Adriatic Italy. He attended medical school at Ain Shams University Medical School. This was followed by a Residency at Ain Shams Maternity Hospital. He received further training in the UK until his Consultant Post at the University Hospital of North Durham.

Currently, he holds a job as professor of Obstetrics & Gynecology at Ain Shams University. His main interests are Minimal Access Surgery and Fetal Medicine.

Magdy El Ekiaby, MSc M.D.

Dr. Magdy El Ekiaby obtained a MD degree from Cairo University in 1978. He has been a member of Egypt’s National Board of Blood Transfusion, Ministry of Health & Population since 1986 and is serving as a member of the International Society of Blood Transfusion (ISBT) Executive Team, responsible for Arab Transfusion Medicine Forum. He is a member of the organizing Committee of ISBT Working Party on Transfusion Transmitted Diseases and has chaired the Scientific Committee of the XIXth ISBT Cairo Regional Congress, Europe and East Mediterranean, 2009. He is also a Board of Directors member of the World Federation of Hemophilia since 2010.

Dr El Ekiaby has served the haemophilia community in Egypt since 1985, both through his profession as a haematologist and blood transfusion specialist, and as a member of the board and Vice President of the Egyptian Society of Hemophilia. Dr El Ekiaby is currently the Head of Blood Transfusion & Hemophilia Centre, Shabrawishi Hospital, a position held since 1983.

Paul Leo Francis Giangrande,
BSc M.D. FRCP (Lond., Edin., & Ireland) FRCPath FRCPCH

Paul Giangrande retired from his position as consultant hematologist at the Oxford University Hospitals NHS Trust and Director of the Oxford Haemophilia Centre in June 2015. He is a member of the Nuffield Department of Medicine in the University of Oxford. He qualified in Medicine from the University of Manchester in 1979 after previously obtaining a First Class Bachelor of Science (BSc) degree in pharmacology. After obtaining postgraduate qualifications in both adult and pediatric medicine he trained in hematology in various major hospitals in London. He obtained a research doctorate in 1991 for his work at the Royal Free Hospital in London on immunological aspects of hemophilia treatment. He subsequently worked at the Milan Haemophilia Centre with Professor Mannucci between 1989-1990 before being appointed to his current position in Oxford in 1991.

He served as elected Vice President (Medical) of the World Federation of Hemophilia from 2000 to 2008 inclusive and has wide international experience in the field. He remains as Chairman of the Medical Advisory Board of the European Haemophilia Consortium (EHC) and serves as examiner in hematology for the Royal College of Pathologists.

Nevine Kassim, M.D.

Dr. Kassim is currently Section Head, Hemostasis and Thrombosis, Clinical Pathology Dept and ex-head of the Dept of Clinical pathology at Ain Shams University and president of the Egyptian Society on Thrombosis and Hemostasis. She has published about 20 publications, mostly in the field of thrombosis and hemostasis. She has been the driving force to increase the awareness of the topic of thrombosis and hemostasis within Egypt and the region.

She was the president of an educational symposium with the aid of ISTH in Cairo 2005, president of the 56th SSC meeting of ISTH in 2010, Cairo. She is the counselor of Egypt for the EMLTD (European & Mediterranean League on Thrombosis) and responsible for organizing the yearly conference of the Egyptian Society on T & H. She had received many awards: from Ain Shams University for her role as head of Clinical Pathology Dept., ISTH for organizing SCC 2010 and the Egyptian Medical syndicate for her achievements in the field of Clinical pathology.

Lai Heng Lee, M.D.

Dr. Lee received her medical and advanced specialist training in hematology in Singapore. She is the immediate past head and currently a senior consultant with the Department of Haematology at Singapore General Hospital. She has an interest in the sub-specialty of thrombosis and hemostasis and was instrumental in the setting up of the anticoagulation clinic, promoting patient safety in anticoagulation therapy and has refined the practice of anticoagulation monitoring services in this hospital. Her interest in hematology research has resulted in more than 50 publications in peer reviewed journals.

Dr. Lee is also actively involved in medical education in her roles as Clinical Associate Professor Yong Loo Lin School of Medicine, NUS and Adjunct Associate Professor, Duke-NUS Graduate Medical School. Dr. Lee also participates actively in the local and regional professional scenes with her roles as Chairman of the Asia-Pacific Society for Thrombosis and Haemostasis, Council Member of the College of Physicians Singapore, the past President of the Singapore Society of Haematology and past Chairman of the Chapter of Haematology, College of Physicians, Singapore.

David Lillicrap, M.D., FRCPC

Dr. Lillicrap is a Professor in the Department of Pathology and Molecular Medicine at Queen’s University, Kingston, Canada. Since 2000, he has been the recipient of a Canada Research Chair in Molecular Hemostasis and is a past Career Investigator of the Heart and Stroke Foundation of Ontario. He has served on the Gene Therapy Working Group of the US National Hemophilia Foundation (NHF) and has been a member of NHF’s Medical and Scientific Advisory Committee. He is the Chair of the Research Committee of the World Federation of Hemophilia (WFH) and is a member of the Medical Advisory Board of the WFH. He recently completed a three-year term as the chairperson of the ISTH's SSC Subcommittee on von Willebrand Factor, and is the Immediate Past Chair of the Society’s SSC.

He is an Associate Editor of the journal Blood, and a member of the editorial board of the British Journal of Haematology. His research program relates to molecular aspects of the hemostatic system with particular emphasis on novel therapeutic approaches and immunological complications of hemophilia A, and the genetics, biology and pathobiology of von Willebrand Factor.

Claire McLintock, M.D.

Dr. McLintock is a hematologist and obstetric physician with an interest in thrombosis and hemostasis, medical disorders in pregnancy including preeclampsia, venous thromboembolism, management of pregnant women with mechanical heart valves and obstetric hemorrhage. She is a graduate of the University of Edinburgh and completed her postgraduate studies in clinical and laboratory hematology gaining Fellowship of the Royal Australasian College of Physicians and Royal College of Pathologists of Australasia. Dr. McLintock is Clinical Director of Regional Maternity Services at National Women's Health, Auckland City Hospital, and is the leader of Maternal Fetal Medicine, Obstetric Medicine and Diabetes. She works as an obstetric physician providing care for women with medical complications in pregnancy at NWH.

Dr. McLintock serves on Council for the ISTH and is Chair of the Membership and Communications committee, Vice-chair of the Education and Outreach Committee and leads the Working Group developing the Society’s core curriculum in clinical thrombosis and hemostasis. She is a past-President of the Australasian Society of Thrombosis and Haemostasis and of the Society of Obstetric Medicine of Australia and New Zealand. She leads the NZ branch of the Australasian Maternity Outcomes Surveillance System looking at severe maternal morbidity in complications.

Tarek Owaidah, M.D.

Tarek M.A. Owaidah received his M.B.B.S from King Suad University Medical College in Saudi Arabia. He then earned a FRCPA, Fellowship of the Royal College of Pathologists of Australasia in Australia. This was followed by a fellowship at the American College of Physicians in the United States. Dr. Owaidah has authored more than 40 peer-reviewed papers, book chapter, and review articles.

He currently holds positions of Deputy Director, Blood Bank and Transfusion Services and Section Head, Point of Care Testing in the Department of Pathology and Laboratory Medicine at King Faisal Specialist Hospital & Research Center. He is also a consultant hematologist, Section of Internal Medicine, Department of Medicine at King Faisal, as well as a part time consultant hematologist at the College of Medicine, King Saud University Hospital. In addition, Dr. Owaidah is an associate professor at Al Faisal University.

Flora Peyvandi, M.D., Ph.D

Flora Peyvandi is an Associate Professor of Internal Medicine at the University of Milan and the Director of the Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy. Her entire academic and clinical career has been dedicated to the knowledge of the underlying causes of coagulation diseases for the purpose of determining the best medical approach to treatment for patients. Testifying to this from the scientific point of view are more than 240 studies published in well-reputed specialized journals as well as the positions she holds in World Federation of Hemophilia and ISTH. As Chair of the Factor VIII, Factor IX, and Rare Coagulation Disorders ISTH-SSC subcommittee she helped to developed a great number of projects that focused on harmonizing clinical methods used in laboratories as well as evaluating the effectiveness and safety of therapeutic products.

Since 1998, she has been the recipient of more than 40 project grants funded by Italian and International organisations. In particular she has been the principal investigator of a project on “Establishment of an European Network of Rare Bleeding Disorders” funded by the commission of the European Communities - Public Health Executive Agency and she is now recipient as leader of the workpackage dedicated to the prospective study of rare bleeding disorders within the project “European Haemophilia Network (EUHANET)” funded by the commission of the European Union - the Executive Agency for Health and Consumers. In 2014 she was awarded the “Great Hippocrates," as the Italian medical researcher of the year.

Frits Rosendaal, M.D., Ph.D

Frits R. Rosendaal M.D. Ph.D., is professor of Clinical Epidemiology at the Leiden University Medical Center, the Netherlands, where he chairs the department of Clinical Epidemiology and is co-appointed at the department of Thrombosis and Haemostasis. He studied medicine in Rotterdam and obtained his PhD at Leiden University, with a thesis on hemophilia, in 1989. His main research interest is hemostasis and thrombosis, and he published over 700 papers in the field. In the field of thrombosis, he designed the Leiden Thrombophilia Study (LETS) and MEGA study that have been instrumental in the identification of a series of risk factors for thrombosis, amongst which factor V Leiden, prothrombin 20210A and fibrinogeen gamma 10034T. In the field of hemophilia, he has coordinated the national surveys on hemophilia (‘Haemophilia in the Netherlands’), since 1985. Within the general field of aetiology of disease, he has a specific interest in genetics and in side-effects of medicinal drugs.

He has been Chairman of the Council of the ISTH, and was President of the 24th ISTH Congress in Amsterdam in 2013. Currently, he is Editor in Chief of the Journal of Thrombosis and Haemostasis. He is elected member of the Netherlands Royal Academy of Arts and Sciences, and the German Academy Leopoldina.

Key Dates

January 31, 2015
Registration Opens

July 16, 2015
Early Registration Closes

September 14-17, 2015
ISTH Advanced Training Course, Dubai

International Society on Thrombosis and Haemostasis, Inc.